DBT (ALDBT.PA) Stock Fundamental Analysis
Europe • Euronext Paris • EPA:ALDBT • FR001400LO86
0.073 EUR
+0.04 (+100.55%)
Last: Jan 30, 2026, 07:00 PM
Overall ALDBT gets a fundamental rating of 2 out of 10. We evaluated ALDBT against 67 industry peers in the Electrical Equipment industry. ALDBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALDBT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- ALDBT had negative earnings in the past year.
- ALDBT had a negative operating cash flow in the past year.
- In the past 5 years ALDBT always reported negative net income.
- ALDBT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -14.55%, ALDBT is doing worse than 81.33% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -46.17%, ALDBT is doing worse than 81.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.55% | ||
| ROE | -46.17% | ||
| ROIC | N/A |
ROA(3y)-23.56%
ROA(5y)-31%
ROE(3y)-52.67%
ROE(5y)-63.14%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALDBT has a Gross Margin (31.98%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of ALDBT has grown nicely.
- ALDBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y1.62%
2. Health
2.1 Basic Checks
- ALDBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ALDBT has more shares outstanding
- Compared to 5 years ago, ALDBT has less shares outstanding
- The debt/assets ratio for ALDBT is higher compared to a year ago.
2.2 Solvency
- ALDBT has an Altman-Z score of -0.79. This is a bad value and indicates that ALDBT is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -0.79, ALDBT is doing worse than 84.00% of the companies in the same industry.
- ALDBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.79 |
ROIC/WACCN/A
WACC4.05%
2.3 Liquidity
- ALDBT has a Current Ratio of 0.67. This is a bad value and indicates that ALDBT is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Current ratio of ALDBT (0.67) is worse than 92.00% of its industry peers.
- ALDBT has a Quick Ratio of 0.67. This is a bad value and indicates that ALDBT is not financially healthy enough and could expect problems in meeting its short term obligations.
- ALDBT has a Quick ratio of 0.41. This is amonst the worse of the industry: ALDBT underperforms 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.41 |
3. Growth
3.1 Past
- ALDBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.59%, which is quite impressive.
- ALDBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.47%.
- Measured over the past years, ALDBT shows a small growth in Revenue. The Revenue has been growing by 1.98% on average per year.
EPS 1Y (TTM)87.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.08%
Revenue 1Y (TTM)-18.47%
Revenue growth 3Y32.91%
Revenue growth 5Y1.98%
Sales Q2Q%-29.93%
3.2 Future
- The Earnings Per Share is expected to grow by 24.42% on average over the next years. This is a very strong growth
- The Revenue is expected to decrease by -90.45% on average over the next years. This is quite bad
EPS Next Y28.13%
EPS Next 2Y20.08%
EPS Next 3Y24.42%
EPS Next 5YN/A
Revenue Next Year25.09%
Revenue Next 2Y25.88%
Revenue Next 3Y-90.45%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALDBT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALDBT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as ALDBT's earnings are expected to grow with 24.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.08%
EPS Next 3Y24.42%
5. Dividend
5.1 Amount
- ALDBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DBT / ALDBT.PA FAQ
Can you provide the ChartMill fundamental rating for DBT?
ChartMill assigns a fundamental rating of 2 / 10 to ALDBT.PA.
Can you provide the valuation status for DBT?
ChartMill assigns a valuation rating of 1 / 10 to DBT (ALDBT.PA). This can be considered as Overvalued.
What is the profitability of ALDBT stock?
DBT (ALDBT.PA) has a profitability rating of 1 / 10.
Is the dividend of DBT sustainable?
The dividend rating of DBT (ALDBT.PA) is 0 / 10 and the dividend payout ratio is 0%.